Filing Details

Accession Number:
0000711377-17-000009
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-15 21:31:34
Reporting Period:
2017-05-12
Filing Date:
2017-05-15
Accepted Time:
2017-05-15 21:31:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-12 29,893 $39.61 912,105 No 4 M Direct
Common Stock Acquisiton 2017-05-12 18,576 $47.12 930,681 No 4 M Direct
Common Stock Disposition 2017-05-12 48,469 $61.29 882,212 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2017-05-12 29,893 $0.00 29,893 $39.61
Common Stock Common Stock (Right to Buy) Disposition 2017-05-12 18,576 $0.00 18,576 $47.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
301,001 2019-10-31 No 4 M Direct
282,425 2020-11-08 No 4 M Direct
Footnotes
  1. Options were granted 10/1/2014, have five year lives, and vest in equal annual installments on the first five anniversary dates of the grant
  2. Options were granted 10/8/2015, have five year lives, and vest in equal annual 20% installments on the anniversary date of the grant